avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Egr1 | mm10_v2_chr18_+_34861200_34861215 | 0.16 | 3.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_109453455 Show fit | 9.23 |
ENSMUST00000109844.4
ENSMUST00000109842.2 ENSMUST00000109843.1 ENSMUST00000109846.4 ENSMUST00000173539.1 ENSMUST00000109841.2 |
delta-like 1 homolog (Drosophila) |
|
chr7_-_142659482 Show fit | 8.66 |
ENSMUST00000121128.1
|
insulin-like growth factor 2 |
|
chr12_-_76709997 Show fit | 5.67 |
ENSMUST00000166101.1
|
spectrin beta, erythrocytic |
|
chr4_+_127169131 Show fit | 5.54 |
ENSMUST00000046659.7
|
discs, large (Drosophila) homolog-associated protein 3 |
|
chr5_-_107726017 Show fit | 5.35 |
ENSMUST00000159263.2
|
growth factor independent 1 |
|
chr5_+_137288273 Show fit | 5.13 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
acetylcholinesterase |
|
chr3_-_86920830 Show fit | 4.80 |
ENSMUST00000029719.8
|
doublecortin-like kinase 2 |
|
chr6_+_121636173 Show fit | 4.61 |
ENSMUST00000032203.7
|
alpha-2-macroglobulin |
|
chr2_+_118111876 Show fit | 4.61 |
ENSMUST00000039559.8
|
thrombospondin 1 |
|
chr6_-_60828889 Show fit | 3.65 |
ENSMUST00000114268.3
|
synuclein, alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 10.4 | GO:0032796 | uropod organization(GO:0032796) |
0.3 | 8.9 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
1.1 | 8.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 6.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 5.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 5.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
1.1 | 5.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.0 | 5.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.2 | 4.8 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.5 | 4.6 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 11.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 7.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 6.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.4 | 5.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.7 | 5.1 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 4.8 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 4.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 4.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 3.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.9 | 3.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 10.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 8.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 5.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 5.3 | GO:0008017 | microtubule binding(GO:0008017) |
1.3 | 5.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 5.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 4.7 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 4.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
1.5 | 4.6 | GO:0019959 | interleukin-8 binding(GO:0019959) tumor necrosis factor binding(GO:0043120) |
1.2 | 4.6 | GO:0070052 | collagen V binding(GO:0070052) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 9.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 8.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 7.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 5.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 4.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 4.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 3.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 2.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 2.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 11.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 8.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 7.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 6.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.2 | 5.1 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 4.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 4.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 4.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 3.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |